Evidence map›Paper›PMID 30381421›Full record

ReviewJournal of clinical microbiology2019

Genome-Based Prediction of Bacterial Antibiotic Resistance.

Michelle Su, Sarah W Satola, Timothy D Read

Abstract readReview
In one paragraph

Review in Journal of clinical microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 187 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
187citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

187 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Beyond the Usual Suspects: EmergingInternational journal of molecular sciences · 2026
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. [Clinical and molecular characteristics of neonatalZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Article
  14. Putative azithromycin resistance mutations inAntimicrobial agents and chemotherapy · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Harnessing interpretable deep learning to predict resistance inFrontiers in cellular and infection microbiology · 2026
    Article

127 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michelle SuDepartment of Infectious Diseases, Emory University, Atlanta, Georgia, USA.
Sarah W SatolaDepartment of Infectious Diseases, Emory University, Atlanta, Georgia, USA.
Timothy D ReadDepartment of Infectious Diseases, Emory University, Atlanta, Georgia, USA tread@emory.edu.

Funding

Antimicrobial Resistance and Therapeutic Discovery Training ProgramT32AI106699 · NIAID · EMORY UNIVERSITY · PI Graeme L Conn, Joanna B Goldberg · 2014 to 2026
$2.7M
Genomics-based prediction of antibiotic failure in S. aureus infectionsR21AI121860 · NIAID · EMORY UNIVERSITY · PI READ, TIMOTHY D., SATOLA, SARAH W · 2016 to 2017
$429k
NIAID NIH HHS R21 AI121860NIAID NIH HHS T32 AI106699
6 · The paper itself

Abstract

Clinical microbiology has long relied on growing bacteria in culture to determine antimicrobial susceptibility profiles, but the use of whole-genome sequencing for antibiotic susceptibility testing (WGS-AST) is now a powerful alternative. This review discusses the technologies that made this possible and presents results from recent studies to predict resistance based on genome sequences. We examine differences between calling antibiotic resistance profiles by the simple presence or absence of previously known genes and single-nucleotide polymorphisms (SNPs) against approaches that deploy machine learning and statistical models. Often, the limitations to genome-based prediction arise from limitations of accuracy of culture-based AST in addition to an incomplete knowledge of the genetic basis of resistance. However, we need to maintain phenotypic testing even as genome-based prediction becomes more widespread to ensure that the results do not diverge over time. We argue that standardization of WGS-AST by challenge with consistently phenotyped strain sets of defined genetic diversity is necessary to compare the efficacy of methods of prediction of antibiotic resistance based on genome sequences.

Indexed as

Genome, BacterialAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialAnti-Bacterial Agentsantibiotic resistancegenome-based prediction

Identifiers

PMID30381421
PMCPMC6425178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.